Achieve Life Sciences, Inc. (ACHV) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
the bull case· 4
9
disclosed supplier and customer ties in SEC filings
sec filingsedgar111
managers reporting a position in filings
13fJun 30 '260 of 12
largest reporting managers cutting their stake in the latest quarter
13fJun 30 '26+111.19%
change in shares held by the ten largest reporting managers this quarter
13fJun 30 '26the bear case· 3
3
funds on file reporting a position in ACHV
n-portas of Jun 30 '260.08%
State Street SPDR S&P Biotech ETF assets as the largest fund weight
n-portJun 30 '2616
managers whose positions together make up four fifths of reported value
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 9 '26 report. Not a forecast, not advice.
Achieve Life Sciences, Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 2835, In Vitro & In Vivo Diagnostic Substances, from each company's own filings. Largest first.
High 8.07 at 3:00 pm ET, low 7.90 at 12:00 pm ET.
Achieve Life Sciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · In Vitro & In Vivo Diagnostic Substances
tall tick = annual report · 1 on record
111 managers report a position worth $553.6M between them, and 16 of them hold 80% of it.
ACHV (Achieve Life Sciences, Inc.) has 7 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.